 Dae Won Park
Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 7 | 2018 | 464 | 1.940 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2022 | 504 | 1.780 |
Why?
| | Biomimetic Materials | 4 | 2017 | 64 | 1.570 |
Why?
| | Tissue Scaffolds | 4 | 2017 | 180 | 1.340 |
Why?
| | Gels | 3 | 2020 | 72 | 1.150 |
Why?
| | Delayed-Action Preparations | 3 | 2018 | 158 | 1.130 |
Why?
| | Polyurethanes | 2 | 2015 | 36 | 0.940 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1486 | 0.820 |
Why?
| | Hydrogels | 3 | 2022 | 581 | 0.790 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 174 | 0.780 |
Why?
| | Temperature | 2 | 2014 | 589 | 0.750 |
Why?
| | Acrylamides | 2 | 2018 | 43 | 0.750 |
Why?
| | Drug Delivery Systems | 2 | 2014 | 301 | 0.740 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 22 | 0.630 |
Why?
| | Materials Testing | 3 | 2018 | 357 | 0.630 |
Why?
| | Sulfones | 1 | 2018 | 98 | 0.610 |
Why?
| | Tissue Engineering | 3 | 2018 | 366 | 0.590 |
Why?
| | Neurites | 2 | 2016 | 44 | 0.590 |
Why?
| | Nerve Regeneration | 2 | 2016 | 53 | 0.580 |
Why?
| | Air Filters | 1 | 2015 | 2 | 0.530 |
Why?
| | Retinal Ganglion Cells | 1 | 2016 | 92 | 0.520 |
Why?
| | Acrylic Resins | 2 | 2018 | 38 | 0.520 |
Why?
| | Myocardial Infarction | 1 | 2022 | 931 | 0.510 |
Why?
| | Stroke Volume | 1 | 2018 | 508 | 0.510 |
Why?
| | Meningomyelocele | 3 | 2021 | 57 | 0.510 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 235 | 0.500 |
Why?
| | Biodegradable Plastics | 1 | 2014 | 4 | 0.490 |
Why?
| | Micelles | 1 | 2014 | 34 | 0.480 |
Why?
| | Triamcinolone Acetonide | 1 | 2014 | 27 | 0.480 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 65 | 0.480 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 418 | 0.470 |
Why?
| | Neurogenesis | 1 | 2015 | 102 | 0.470 |
Why?
| | Neural Stem Cells | 1 | 2015 | 114 | 0.460 |
Why?
| | Heparin | 1 | 2014 | 226 | 0.440 |
Why?
| | Heart Ventricles | 1 | 2018 | 712 | 0.430 |
Why?
| | Motor Neurons | 1 | 2015 | 213 | 0.430 |
Why?
| | Myocardium | 1 | 2018 | 929 | 0.430 |
Why?
| | Silicon Dioxide | 1 | 2013 | 94 | 0.430 |
Why?
| | Wet Macular Degeneration | 1 | 2013 | 32 | 0.420 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 664 | 0.410 |
Why?
| | Animals | 16 | 2022 | 32120 | 0.410 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 216 | 0.380 |
Why?
| | Anti-Inflammatory Agents | 1 | 2014 | 447 | 0.380 |
Why?
| | Contrast Media | 1 | 2013 | 366 | 0.370 |
Why?
| | Nanoparticles | 1 | 2013 | 318 | 0.350 |
Why?
| | Peptides | 1 | 2013 | 862 | 0.310 |
Why?
| | Cattle | 3 | 2017 | 935 | 0.310 |
Why?
| | Mice | 7 | 2022 | 15073 | 0.290 |
Why?
| | Antiviral Agents | 1 | 2013 | 648 | 0.290 |
Why?
| | Biomimetics | 2 | 2016 | 36 | 0.270 |
Why?
| | Laminin | 2 | 2016 | 69 | 0.250 |
Why?
| | Rats | 5 | 2017 | 5035 | 0.250 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2014 | 194 | 0.230 |
Why?
| | Nanofibers | 2 | 2013 | 19 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1891 | 0.210 |
Why?
| | Breast Neoplasms | 1 | 2013 | 1870 | 0.200 |
Why?
| | Interleukin-10 | 1 | 2022 | 304 | 0.180 |
Why?
| | Tissue Adhesives | 1 | 2020 | 18 | 0.180 |
Why?
| | Urea | 1 | 2020 | 69 | 0.170 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 81 | 0.170 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 90 | 0.170 |
Why?
| | Fetoscopy | 1 | 2018 | 28 | 0.160 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 137 | 0.160 |
Why?
| | Surgical Wound | 1 | 2018 | 17 | 0.160 |
Why?
| | Alginates | 1 | 2018 | 44 | 0.150 |
Why?
| | Dopamine | 1 | 2020 | 237 | 0.150 |
Why?
| | Organophosphorus Compounds | 1 | 2018 | 73 | 0.150 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 43 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2013 | 2196 | 0.140 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 105 | 0.130 |
Why?
| | Myocytes, Cardiac | 2 | 2017 | 456 | 0.130 |
Why?
| | Health Facilities | 1 | 2015 | 70 | 0.130 |
Why?
| | Sulfonic Acids | 1 | 2014 | 12 | 0.120 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 21 | 0.120 |
Why?
| | Injections, Intraocular | 1 | 2014 | 10 | 0.120 |
Why?
| | Phase Transition | 1 | 2014 | 28 | 0.120 |
Why?
| | Axons | 1 | 2016 | 180 | 0.120 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 156 | 0.120 |
Why?
| | Biocompatible Materials | 1 | 2018 | 379 | 0.120 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 77 | 0.120 |
Why?
| | Circular Dichroism | 1 | 2014 | 135 | 0.120 |
Why?
| | Static Electricity | 1 | 2014 | 117 | 0.120 |
Why?
| | Lysine | 1 | 2016 | 243 | 0.120 |
Why?
| | Stem Cell Transplantation | 1 | 2015 | 151 | 0.120 |
Why?
| | Retina | 1 | 2016 | 269 | 0.120 |
Why?
| | PC12 Cells | 1 | 2013 | 37 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 165 | 0.120 |
Why?
| | Nerve Growth Factor | 1 | 2013 | 27 | 0.110 |
Why?
| | Porosity | 1 | 2013 | 93 | 0.110 |
Why?
| | Polyesters | 1 | 2013 | 65 | 0.110 |
Why?
| | Trastuzumab | 1 | 2013 | 89 | 0.110 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 180 | 0.110 |
Why?
| | Cell Death | 1 | 2014 | 324 | 0.110 |
Why?
| | Endothelium, Corneal | 1 | 2013 | 15 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2262 | 0.110 |
Why?
| | Gram-Negative Bacteria | 1 | 2013 | 67 | 0.110 |
Why?
| | Immunoassay | 1 | 2013 | 97 | 0.100 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 510 | 0.100 |
Why?
| | Bevacizumab | 1 | 2013 | 118 | 0.100 |
Why?
| | Particle Size | 1 | 2013 | 341 | 0.100 |
Why?
| | Surface Properties | 1 | 2013 | 397 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 3916 | 0.100 |
Why?
| | Bacteria | 1 | 2018 | 731 | 0.100 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 850 | 0.100 |
Why?
| | Oligopeptides | 1 | 2013 | 248 | 0.100 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 299 | 0.100 |
Why?
| | Cell Survival | 1 | 2013 | 1026 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1643 | 0.090 |
Why?
| | Ultrasonography | 1 | 2013 | 671 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1868 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2503 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 386 | 0.080 |
Why?
| | Escherichia coli | 1 | 2013 | 730 | 0.080 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 4767 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2655 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2013 | 1706 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2020 | 779 | 0.070 |
Why?
| | Male | 5 | 2020 | 56123 | 0.060 |
Why?
| | Pregnancy | 3 | 2021 | 5555 | 0.060 |
Why?
| | Humans | 4 | 2018 | 115890 | 0.060 |
Why?
| | Bivalvia | 1 | 2020 | 5 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 766 | 0.040 |
Why?
| | Spinal Cord | 1 | 2021 | 351 | 0.040 |
Why?
| | Female | 4 | 2021 | 60076 | 0.040 |
Why?
| | Gelatin | 1 | 2017 | 37 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2018 | 154 | 0.040 |
Why?
| | Fetus | 1 | 2021 | 703 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1319 | 0.030 |
Why?
| | Transcription Factors | 1 | 2020 | 1530 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3583 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2382 | 0.020 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|